Question to the Department of Health and Social Care:

To ask Her Majesty's Government what are the (1) planned order quantities, and (2) delivery dates, for the COVID-19 antibody drugs Molnupiravir and Ritonavir; and what is the (a) current, and (b) planned, geographic distribution of Molnupiravir and Ritonavir across England.

The Government has secured 480,000 patient courses of molnupiravir and 250,000 patient courses of PF-07321332 in combination with ritonavir. Information on delivery and distribution of these items is dependent on the companies’ supply chains and receipt of the appropriate marketing authorisations from the Medicines and Healthcare products Regulatory Agency. We are working with NHS England and NHS Improvement, the UK Health Security Agency and the devolved administrations to ensure that, when available, these treatments will be accessible to those who are most at risk of developing severe disease. Further details will be announced in due course.